Implementation of stroke teams and simulation training shortened process times in a regional stroke network-A network-wide prospective trial

PLoS One. 2017 Dec 5;12(12):e0188231. doi: 10.1371/journal.pone.0188231. eCollection 2017.

Abstract

Background: To meet the requirements imposed by the time-dependency of acute stroke therapies, it is necessary 1) to initiate structural and cultural changes in the breadth of stroke-ready hospitals and 2) to find new ways to train the personnel treating patients with acute stroke. We aimed to implement and validate a composite intervention of a stroke team algorithm and simulation-based stroke team training as an effective quality initiative in our regional interdisciplinary neurovascular network consisting of 7 stroke units.

Methods: We recorded door-to-needle times of all consecutive stroke patients receiving thrombolysis at seven stroke units for 3 months before and after a 2 month intervention which included setting up a team-based stroke workflow at each stroke unit, a train-the-trainer seminar for stroke team simulation training and a stroke team simulation training session at each hospital as well as a recommendation to take up regular stroke team trainings.

Results: The intervention reduced the network-wide median door-to-needle time by 12 minutes from 43,0 (IQR 29,8-60,0, n = 122) to 31,0 (IQR 24,0-42,0, n = 112) minutes (p < 0.001) and substantially increased the share of patients receiving thrombolysis within 30 minutes of hospital arrival from 41.5% to 59.6% (p < 0.001). Stroke team training participants stated a significant increase in knowledge on the topic of acute stroke care and in the perception of patient safety. The overall course concept was regarded as highly useful by most participants from different professional backgrounds.

Conclusions: The composite intervention of a binding team-based algorithm and stroke team simulation training showed to be well-transferable in our regional stroke network. We provide suggestions and materials for similar campaigns in other stroke networks.

MeSH terms

  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Care Team*
  • Prospective Studies
  • Stroke / therapy*
  • Thrombolytic Therapy

Grants and funding

Boehringer Ingelheim supported this study with a research grant of 10.000,00 Euros to WP. The funder had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.